Suppr超能文献

酰基-2-氨基苯并咪唑类:一类靶向代谢型谷氨酸受体5(mGluR5)的新型神经保护剂。

Acyl-2-aminobenzimidazoles: a novel class of neuroprotective agents targeting mGluR5.

作者信息

He Xinhua, Lakkaraju Sirish K, Hanscom Marie, Zhao Zaorui, Wu Junfang, Stoica Bogdan, MacKerell Alexander D, Faden Alan I, Xue Fengtian

机构信息

Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 Penn Street, Baltimore, MD 21201, United States.

Department of Anesthesiology and Center for Shock, Trauma and Anesthesiology Research (STAR), University of Maryland School of Medicine, Baltimore, MD 21201, United States.

出版信息

Bioorg Med Chem. 2015 May 1;23(9):2211-20. doi: 10.1016/j.bmc.2015.02.054. Epub 2015 Mar 6.

Abstract

Positive allosteric modulators (PAMs) of the metabotropic glutamate receptor 5 (mGluR5) are promising therapeutic agents for treating traumatic brain injury (TBI). Using computational and medicinal methods, the structure-activity relationship of a class of acyl-2-aminobenzimidazoles (1-26) is reported. The new compounds are designed based on the chemical structure of 3,3'-difluorobenzaldazine (DFB), a known mGluR5 PAM. Ligand design and prediction of binding affinities of the new compounds have been performed using the site identification by ligand competitive saturation (SILCS) method. Binding affinities of the compounds to the transmembrane domain of mGluR5 have been evaluated using nitric oxide (NO) production assay, while the safety of the compounds is tested. One new compound found in this study, compound 22, showed promising activity with an IC₅₀ value of 6.4 μM, which is ∼20 fold more potent than that of DFB. Compound 22 represents a new lead for possible development as a treatment for TBI and related neurodegenerative conditions.

摘要

代谢型谷氨酸受体5(mGluR5)的正变构调节剂(PAM)是治疗创伤性脑损伤(TBI)的有前景的治疗药物。运用计算和药物方法,报道了一类酰基-2-氨基苯并咪唑(1-26)的构效关系。新化合物基于已知的mGluR5 PAM 3,3'-二氟苯甲醛腙(DFB)的化学结构设计。使用配体竞争饱和位点识别(SILCS)方法进行了新化合物的配体设计和结合亲和力预测。使用一氧化氮(NO)生成测定法评估了化合物与mGluR5跨膜结构域的结合亲和力,同时测试了化合物的安全性。本研究中发现的一种新化合物,即化合物22,显示出有前景的活性,IC₅₀值为6.4 μM,比DFB的效力高约20倍。化合物22代表了一种可能作为TBI及相关神经退行性疾病治疗药物开发的新先导物。

相似文献

1
Acyl-2-aminobenzimidazoles: a novel class of neuroprotective agents targeting mGluR5.
Bioorg Med Chem. 2015 May 1;23(9):2211-20. doi: 10.1016/j.bmc.2015.02.054. Epub 2015 Mar 6.
2
Cyclopropyl-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5.
Bioorg Med Chem Lett. 2015 Jun 1;25(11):2275-9. doi: 10.1016/j.bmcl.2015.04.042. Epub 2015 Apr 20.
4
Positive allosteric modulators (PAMs) of metabotropic glutamate receptor 5 (mGluR5) attenuate microglial activation.
CNS Neurol Disord Drug Targets. 2014;13(4):558-66. doi: 10.2174/18715273113126660199.

引用本文的文献

1
A Comprehensive Account on Recent Progress in Pharmacological Activities of Benzimidazole Derivatives.
Front Pharmacol. 2021 Nov 3;12:762807. doi: 10.3389/fphar.2021.762807. eCollection 2021.
3
Hit-to-lead optimization of novel benzimidazole phenylacetamides as broad spectrum trypanosomacides.
RSC Med Chem. 2020 May 29;11(6):685-695. doi: 10.1039/d0md00058b. eCollection 2020 Jun 1.
5
Optimization and Evaluation of Site-Identification by Ligand Competitive Saturation (SILCS) as a Tool for Target-Based Ligand Optimization.
J Chem Inf Model. 2019 Jun 24;59(6):3018-3035. doi: 10.1021/acs.jcim.9b00210. Epub 2019 May 8.
6
Mixed-Probe Simulation and Probe-Derived Surface Topography Map Analysis for Ligand Binding Site Identification.
J Chem Theory Comput. 2017 Apr 11;13(4):1851-1861. doi: 10.1021/acs.jctc.7b00130. Epub 2017 Mar 13.
8
Driving Structure-Based Drug Discovery through Cosolvent Molecular Dynamics.
J Med Chem. 2016 Dec 8;59(23):10383-10399. doi: 10.1021/acs.jmedchem.6b00399. Epub 2016 Aug 17.
10
Cyclopropyl-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5.
Bioorg Med Chem Lett. 2015 Jun 1;25(11):2275-9. doi: 10.1016/j.bmcl.2015.04.042. Epub 2015 Apr 20.

本文引用的文献

1
GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.
J Chem Theory Comput. 2008 Mar;4(3):435-47. doi: 10.1021/ct700301q.
4
Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator.
Science. 2014 Apr 4;344(6179):58-64. doi: 10.1126/science.1249489. Epub 2014 Mar 6.
5
Inclusion of multiple fragment types in the site identification by ligand competitive saturation (SILCS) approach.
J Chem Inf Model. 2013 Dec 23;53(12):3384-98. doi: 10.1021/ci4005628. Epub 2013 Nov 25.
6
Positive allosteric modulators (PAMs) of metabotropic glutamate receptor 5 (mGluR5) attenuate microglial activation.
CNS Neurol Disord Drug Targets. 2014;13(4):558-66. doi: 10.2174/18715273113126660199.
8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验